Template:90Y-Ibritumomab Tiuxetan/Metadata: Difference between revisions

From Citizendium
Jump to navigation Jump to search
m (Text replacement - "variant =" to "variant = BE")
Tag: Reverted
m (Text replacement - "variant =" to "variant = BE")
Tag: Reverted
Line 2: Line 2:
<!--general article properties-->
<!--general article properties-->
|      pagename = 90Y-Ibritumomab Tiuxetan
|      pagename = 90Y-Ibritumomab Tiuxetan
|        variant = BE BE
|        variant = BE BE BE
<!--Required for checklist-->
<!--Required for checklist-->
|            abc = 90Y-Ibritumomab Tiuxetan
|            abc = 90Y-Ibritumomab Tiuxetan

Revision as of 08:59, 15 March 2024

This article is developing and not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 

Click here to edit this metadata using the metadata form.

This is a central location for all information relating to the 90Y-Ibritumomab Tiuxetan cluster. It is critical to keep this page updated since the {{subpages}} and related templates use this information for the placement of categories and header templates in the cluster. General article properties

pagename = 90Y-Ibritumomab Tiuxetan
variant = BE BE BE
Article size = 11,452 bytes
Cluster subpages

Required for checklist

abc = 90Y-Ibritumomab Tiuxetan
cat_check = yes
status = 2
underlinked = yes
cleanup = yes
Workgroup designations:
cat1 = Health Sciences
cat2 =
cat3 =
Subworkgroup designations:
sub1=
sub2=
sub3=
Article specific tabs:
tab1=
tab2=
tab3=

Required for the ToApprove template

article url =
subpage url =
cluster =
now =
ToA editor =
ToA editor2 =
ToA editor3 =
ToA editor4 =
date =

Required for the Approved template

The status parameter in the checklist (see above) of approved versions must be set to 0 (zero).
A editor =
A editor2 =
A editor3 =
A editor4 =